Literature DB >> 6107166

Can insulin-treated diabetics be given beta-adrenergic-blocking drugs?

U Smith, G Blohmé, I Lager, P Lönnroth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107166      PMCID: PMC1714602          DOI: 10.1136/bmj.281.6248.1143-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.

Authors:  S P Deacon; D Barnett
Journal:  Br Med J       Date:  1976-07-31

2.  Observations in man of hypoglycaemia during selective and non-selective beta-blockade.

Authors:  N M Davidson; R J Corrall; T R Shaw; E B French
Journal:  Scott Med J       Date:  1977-01       Impact factor: 0.729

3.  Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics.

Authors:  S P Deacon; A Karunanayake; D Barnett
Journal:  Br Med J       Date:  1977-11-12

4.  Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.

Authors:  I Lager; G Blohmé; U Smith
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

5.  Modification by propranolol of cardiovascular effects of induced hypoglycaemia.

Authors:  R H Lloyd-Mostyn; S Oram
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

  5 in total
  4 in total

Review 1.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 2.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 3.  Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.

Authors:  G L Plosker; S P Clissold
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

4.  Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.

Authors:  D Kerr; I A MacDonald; S R Heller; R B Tattersall
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.